STABEN STEVEN enters LYCIA THERAPEUTICS, INC. with 55.45K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 10/22/2026ACC: 0002159565-26-000003
Officer10% Owner· Chief Scientific Officer
Since Oct 2026
55.45K
Baseline shares
100% direct
55.45K
Direct ownership
1 position
454.68K
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned55.45K
Total
55.45K direct55.45K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 55.45K | Direct |
| Total | 55.45K | 55.45K direct |
Derivative Holdings4
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
166.34K
Shares owned
N/A
Exercise price
1.63
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
22.18K
Shares owned
N/A
Exercise price
2.35
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
110.90K
Shares owned
N/A
Exercise price
3.70
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
155.25K
Shares owned
N/A
Exercise price
2.44
Expiration
—
Exercise window
—
Total
Underlying
454.68K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 1.63 | — | — | 166.34K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 2.35 | — | — | 22.18K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 3.70 | — | — | 110.90K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 2.44 | — | — | 155.25K | N/A |
| Total | 454.68K | 0.00 | ||||